A detailed history of Amalgamated Bank transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,353 shares of STTK stock, worth $1,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,353
Previous 1,353 -0.0%
Holding current value
$1,488
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.56 - $11.18 $4,816 - $15,126
1,353 New
1,353 $5,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $4.59 $11,180 - $19,007
-4,141 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$4.22 - $8.89 $17,475 - $36,813
4,141 New
4,141 $18,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.